CB-1922

N/A

Report date: 2025/11/17 15:14:37

NME

Base Information

Drug NameCB-1922

Drug Alias NameSpirHSynthetic steroidal lactoneCB-1922

ClassificationSmall molecules > Steroids

Mechanisms of ActionAldosterone antagonists

TargetsAldosterone

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Africa

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCanopus

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCanopus

Active IndicationsN/A

Inactive IndicationsHIV Infections

ATC CodeN/A